---
canonical_url: https://www.stockexpertai.com/earnings/c
last_updated: 2026-07-17T06:15:59.786Z
---

# Citigroup Inc. (C) Q1 FY2027 Earnings Preview

> This content was automatically generated with FMP live data + Q2 FY2026 earnings call transcript. Generated: 2026-07-17T06:15:58.008Z. Educational tool, not investment advice.

---

## Quick Summary

| Field | Value | Source |
|---|---|---|
| Price | $131.72 (▼ -2.35%) | fmp:quote |
| Market Cap | $225.9B | fmp:profile |
| 52w range | $87.94 – $147.96 | fmp:quote |
| Earnings | Tue 13 Oct | fmp:earnings-history |
| EPS estimate | $2.71 (+46% YoY) | fmp:earnings-estimate |
| Revenue estimate | $23.6B | fmp:earnings-estimate |
| Beat streak | 2/4 | fmp:earnings-history |
| Rating | C+ (overall 2/5) | fmp:ratings |
| Analyst median target | $151 (+14.3% upside) | fmp:price-target-consensus |
| MoonshotScore | 44/100 | derived |
| Council | 1/6 bullish | derived |
| Munger verdict | Fairly Valued | derived |

## Citigroup Inc. — Q1 FY2027 Expectations

Q1 consensus: revenue <strong data-source="fmp:earnings-estimate" data-field="estimates.next.revenueAvgLabel">$23.6B</strong><sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.revenueAvg" title="FMP est">[FMP est]</sup>, EPS <strong data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">$2.71</strong><sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg" title="FMP est">[FMP est]</sup>. 2 consecutive quarters of beat<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.beatStreakCount" title="FMP earnings">[FMP earnings]</sup>.

## Quick Take

**Score:** C+ · **Stance:** HOLD · **Council:** 1/6 · **Moonshot:** 44

= MoonshotScore <strong>44</strong><sup class="cite" data-source="derived" data-field="moonshot.score" title="multi-pillar formula">[multi-pillar formula]</sup> + Council <strong>1/6</strong><sup class="cite" data-source="derived" data-field="council.bullishCount" title="6-lens rule">[6-lens rule]</sup>. Form 4: 0 transactions<sup class="cite" data-source="fmp:insider-trading" data-field="insider.txCount" title="FMP Form 4">[FMP Form 4]</sup>.

## Watchlist (0 metrics)

—

## MoonshotScore Pillars

| Pillar | Score | Level | Evidence |
|---|---|---|---|
| Revenue Growth | 0.0 | weak | Q2 vs Q3: growth negative (-43.5%, contraction) |
| Gross Margin | 10.0 | strong | Q2: very high margin (100.0%, software/cloud territory) |
| Operating Leverage | 3.0 | weak | op margin very strong (32.4%, scale leverage) |
| Cash Runway | 3.0 | weak | FCF negative ($-23.3B, external financing needed) |
| R&D Intensity | 3.0 | weak | low R&D investment (1.5%, weak innovation) |
| Price Momentum | 4.0 | medium | RSI 39.9 weak momentum, 50d below |
| News Sentiment | 8.0 | strong | strong buy consensus (78%) |

**Formula:** sum(pillar.score) / (count * 10) * 100. Each pillar deterministic from FMP. Source maps in pillar.formula.

## Council (7-Lens)

| Name | Stance | Context |
|---|---|---|
| Ray Dalio | bull | macro · target upside +14.3% |
| Ken Griffin | bear | flow · 50d MA below |
| Jim Simons | neutral | quant · RSI 40 |
| Klarman | neutral | value · target upside +14.3% |
| Buffett | neutral | quality · ROE score 3/5 |
| Munger | neutral | valuation · target upside +14.3% |

**Formula:** Each lens uses deterministic rule on bundle data. Logged in member.contextTr.

## Munger Lens

- **Verdict:** Fairly Valued
- **Financial Health:** Weak
- **Margin of Safety:** Moderate
- **Interest Coverage:** Adequate
- **ROIC vs WACC:** Tight

**Formula:** verdict=upside>25?Undervalued:>0?Fairly Valued:Overvalued. Each lens deterministic from FMP ratings + priceTarget.

## Technical Levels

- **RSI(14):** 39.9 — momentum zayıf — oversold yakınında değil ama alıcı baskısı az
- **50d MA:** $134 — hisse %1.6 altında — kısa vadeli direnç
- **200d MA:** $117 — hisse %12.6 üstünde — uzun vadeli destek
- **Volume (10d):** -31%

## Past Performance (4 Quarters)

| Quarter | EPS Actual | EPS Estimate | Result | Reaction |
|---|---|---|---|---|
| Q3 FY25 | $1.86 | $1.73 | BEAT | -0.1% |
| Q4 FY25 | $1.19 | $1.80 | MISS | +1.6% |
| Q1 FY26 | $3.06 | $2.65 | BEAT | +1.6% |
| Q2 FY26 | $3.15 | $2.74 | +15.0% EPS | +1.2% |

Q2 (July 14, 2026): EPS $3.15 vs $2.74 est<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.history.0" title="FMP">[FMP]</sup>, +15.0% beat. D+1 movement: +1.2%<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.timeline.3.reactionLabel" title="FMP D+1">[FMP D+1]</sup>. Decline despite beat — market reacted to guidance, not numbers.

## 3 Scenarios

### Scenario A · Beat
**Q1 EPS > $2.71 + CapEx discipline**

Threshold: EPS > $2.71<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est]</sup>.

Target: Break above median target $151<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.median">[FMP target]</sup>; high target $165<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.high">[FMP]</sup> upper bound.

### Scenario B · In-Line
**EPS ≈ $2.71 + CapEx < $1.4B**

Threshold: EPS ≈ $2.71<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est]</sup>, Q1 CapEx < $1.4B<sup class="cite" data-source="fmp:cashflow" data-field="cashflow.qPrev.capexLabel">[FMP]</sup>.

Target: Consolidation in the band between current $132<sup class="cite" data-source="fmp:quote" data-field="quote.price">[FMP]</sup> and median $151<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.median">[FMP]</sup>.

### Scenario C · Miss
**EPS < $2.63 or CapEx ≥ $1.4B**

Threshold: EPS < $2.63<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est×0.97]</sup>.

Target: Current $132 below SMA200 $117<sup class="cite" data-source="fmp:technical" data-field="technical.sma200">[FMP]</sup>, if rejection continues, $99<sup class="cite" data-source="derived" data-field="technical.sma200" data-formula="round(sma200*0.85)">[derived]</sup> support activates.

## Risk Notes

### Primary segment below threshold
Q2: EPS $3.15 vs $2.74 beat<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.history.0" title="FMP">[FMP]</sup>, stock +1.2% D+1<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.timeline.3.reactionLabel" title="FMP">[FMP]</sup>.

### Backlog concentration
No RPO/backlog concentration disclosed in Q2 earnings call.

### Insider trading
Form 4 data is marked in the table — this page does not generate assumptions for this stock.

| Executive | Action | Amount | Date |
|---|---|---|---|


**Net:** — (0 transactions · 0 sells · 0 buys) · Q2 FY26

### CapEx shock
Q2 CapEx $1.4B<sup class="cite" data-source="fmp:cashflow" data-field="cashflow.qPrev.capexLabel" title="FMP cashflow">[FMP cashflow]</sup>. Q2 op margin 32.4%<sup class="cite" data-source="fmp:income" data-field="income.quarters.0.operatingMargin" title="FMP op margin">[FMP op margin]</sup> — this level in Q1 is sensitive to CapEx revision risk.

## Wall Street Consensus

- **Median target:** $151 (+14.3% upside vs current $132)
- **High / Low:** $165 / $139
- **Buy / Hold / Sell:** 18 / 5 / 0
- **Analyst count:** 9 (last quarter), 93 all-time

## Additional Transcript Insights

—

---

*Data source: FMP (live query, 2026-07-17), Q2 FY2026 earnings call transcript (Translated to EN with Gemini 2.0 Flash). Educational tool, not investment advice.*